Comparison of the Treatment Efficacy of Rituximab and Plasmapheresis/Intravenous Immunoglobulin Combination with Historical Control in Chronic Antibody Mediated Rejection

RUHİ, Caglar; Tuğcu, Murat; Kasapoğlu, Umut; Gökçe, Ali; ATA, PINAR; TİTİZ, MESUT

doi:10.5262/tndt.2017.1001.08

Comparison of the Treatment Efficacy of Rituximab and Plasmapheresis/Intravenous Immunoglobulin Combination with Historical Control in Chronic Antibody Mediated Rejection

Copy For Citation

RUHİ B. Ç., Tuğcu M., Kasapoğlu U., Gökçe A. M., ATA P., TİTİZ M. İ.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, vol.26, no.1, pp.48-54, 2017 (Peer-Reviewed Journal)

Publication Type: Article / Article
Volume: 26 Issue: 1
Publication Date: 2017
Doi Number: 10.5262/tndt.2017.1001.08
Journal Name: TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
Page Numbers: pp.48-54
Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

OBJECTIVE: Chronic antibody mediated rejection (CAMR) is a major therapeutic challenge for achieving long-term graft survival; treatment options are limited to several anti-humoral interventions.